Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks

Page 9 of 10

2. Amicus Therapeutics, Inc. (NASDAQ:FOLD)

Number of Hedge Fund Holders: 38  

Perceptive Advisors’ Stake: $19.1 million

Amicus Therapeutics, Inc. (NASDAQ:FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. As per the reports of the third quarter of 2024, the company reported a total revenue of $100.5 million, reflecting a 17% year-over-year increase. This growth was primarily driven by the continued success of the company’s oral precision medicine for Fabry disease. Moreover, Amicus Therapeutics announced the approval and launch of new Pompe disease therapy in the European Union.

Page 9 of 10